tradingkey.logo

Rockwell Medical Inc

RMTI
查看詳細走勢圖
0.854USD
-0.088-9.38%
交易中 美東報價延遲15分鐘
1.61M總市值
虧損本益比TTM

Rockwell Medical Inc

0.854
-0.088-9.38%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-9.38%

5天

-18.70%

1月

-5.21%

6月

-32.78%

今年開始到現在

+2.42%

1年

-25.11%

查看詳細走勢圖

TradingKey Rockwell Medical Inc股票評分

單位: USD 更新時間: 2026-03-27

操作建議

Rockwell Medical Inc當前公司基本面數據相對健康,最新ESG揭露屬於行業領先水平。增長潛力很大。當前估值合理,在藥品行業排名85/157位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為2.50。中期看,股價處於平穩狀態。近一個月,市場表現一般,但基本面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Rockwell Medical Inc評分

相關信息

行業排名
85 / 157
全市場排名
221 / 4542
所屬行業
藥品

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

Rockwell Medical Inc亮點

亮點風險
Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.
業績增長期
公司處於發展階段,最新年度總收入69.26M美元
估值合理
公司最新PE估值-5.89,處於3年歷史合理位
機構減倉
最新機構持股3.38M股,環比減少53.15%
先鋒集團持倉
明星投資者先鋒集團持倉,最新持倉1.40M股
活躍度增加
近期活躍度增加,過去20天平均換手率2.92

分析師目標

基於 2 分析師
買入
評級
3.250
目標均價
+244.97%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Rockwell Medical Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Rockwell Medical Inc簡介

Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.
公司代碼RMTI
公司Rockwell Medical Inc
CEOStrobeck (Mark)
網址https://www.rockwellmed.com/
KeyAI